Japan Offers Experimental Ebola Drug
Enough for 20,000.
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
An unapproved drug to help treat Ebola has been offered up by Japan in an attempt to halt the deadly spread of the virus in western Africa. The medication is called Fabipiravir and was approved for experimental use in Japan in March, though it is waiting approval for testing with the American FDA. “Our country is prepared to provide the yet-to-be approved drug in cooperation with the manufacturer if the WHO requests,” the Japanese government announced, saying it has enough for more than 20,000 people. “Even before the WHO reaches a conclusion, we are ready to respond to individual requests [from medical workers] under certain conditions if it is an urgent case.”
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation